UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031993
Receipt number R000036519
Scientific Title Study for the association between glycometabolism and alcohol metabolism in the glucose tolerance normal person.
Date of disclosure of the study information 2018/03/30
Last modified on 2019/09/30 09:37:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for the association between glycometabolism and alcohol metabolism in the glucose tolerance normal person.

Acronym

Study for the association between glycometabolism and alcohol metabolism.

Scientific Title

Study for the association between glycometabolism and alcohol metabolism in the glucose tolerance normal person.

Scientific Title:Acronym

Study for the association between glycometabolism and alcohol metabolism.

Region

Japan


Condition

Condition

Glucose tolerance normal person

Classification by specialty

Medicine in general Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine an association between glycometabolism and alcohol metabolism in the glucose tolerance normal person.

Basic objectives2

Others

Basic objectives -Others

To examine the following.
(1) Glucose tolerance after the 75g glucose intake.
(2) Glucose tolerance after the 20g alcohol intake
(3) Glucose tolerance and the alcohol metabolism after having taken in 20g alcohol and 75g glucose at the same time.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of the blood glucose change in each endurance test

Key secondary outcomes

(1)Hypoglycemic level, presence or absence of hypoglycemic symptom
(2)Blood alcohol level and loss time
(3)Change of the FFA and triglyceride
(4)Change of the insulin level
(5)Stratified analysis by the subjects background


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Sapporo soft 20%
Trelan-G75

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

(1)subjects with written informed consent
(2)subjects that glucose tolerance is normal
(3)subjects with the alcohol consumption habit

Key exclusion criteria

(1)patients with severe hepatic dysfunction, renal dysfunction, heart failure
(2)subjects of the diathesis that cannot drink,
(3)subjects with a history of poor physical condition and hypersensitivity for alcohol
(4)pregnancy
(5)subjects with impaired glucose tolerance
(6)subjects who drive on test day
(7)subjects who are inadequate to enter this study due to the other reasons by physician's judgments

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Jun
Middle name
Last name Takeuchi

Organization

Sapporo diabetes, thyroid clinic

Division name

Sapporo diabetes, thyroid clinic

Zip code

060-0807

Address

Nishi 2, Kita 7, Kita-ku, Sapporo, Hokkaido, Japan

TEL

011-707-1024

Email

jun_takeuchi@me.com


Public contact

Name of contact person

1st name Jun
Middle name
Last name Takeuchi

Organization

Sapporo diabetes, thyroid clinic

Division name

Sapporo diabetes, thyroid clinic

Zip code

060-0807

Address

Nishi 2, Kita 7, Kita-ku, Sapporo, Hokkaido, Japan

TEL

011-707-1024

Homepage URL


Email

info@sdtc.jp


Sponsor or person

Institute

Sapporo diabetes, thyroid clinic

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical Associations ERB

Address

19-1-1, Odorinishi, Chuo-ku Sapporo-shi, Hokkaido, 060-8581, Japan

Tel

011-611-4181

Email

chiken@spmed.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 05 Day

Date of IRB

2018 Year 03 Month 16 Day

Anticipated trial start date

2018 Year 03 Month 16 Day

Last follow-up date

2018 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 30 Day

Last modified on

2019 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036519


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name